Rocket Lab (NASDAQ:RKLB) Shares Down 4.2% - Here's Why

Key Points

• Rocket Lab shares fell 4.2% to $71.92 amid broad selling across space stocks, valuation concerns and investor caution over the company’s lack of profitability.
• The company has potential growth catalysts, including a possible NASA Neutron contract and the proposed Iridium acquisition, which could significantly improve EBITDA. However, execution risks tied to Neutron’s development, regulatory approval and acquisition financing remain.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and $107.20 price target, but investors face potential dilution of up to 72 million shares and continued insider-selling pressure.

Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) shares traded down 4.2% on Wednesday. The company traded as low as $70.63 and last traded at $71.92. 20,373,747 shares changed hands during mid-day trading, a decline of 12% from the average session volume of 23,069,465 shares. The stock had previously closed at $75.06.

Rocket Lab News Summary

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: NASA opportunity: NASA is reportedly considering Rocket Lab’s Neutron rocket as a launch provider for a planned multiyear procurement supporting its approximately $30 billion lunar-base initiative. Recurring cargo and infrastructure missions could create a substantial long-term revenue opportunity, although no contract has been awarded yet. Rocket Lab Gets a Fresh Opening in NASA’s Moon Push
• Positive Sentiment: Iridium acquisition funding is clearer: Rocket Lab reportedly canceled its planned $3.6 billion bridge loan without drawing on it and has fully funded the proposed Iridium acquisition through debt and equity. Iridium’s roughly $500 million in annual EBITDA could materially improve Rocket Lab’s earnings profile, potentially shifting the combined company from an approximately $80 million EBITDA loss to about $420 million of EBITDA before Neutron contributes. Rocket Lab: Iridium Could Explode EBITDA
• Positive Sentiment: Analyst and backlog support: Coverage continues to identify substantial upside, while Rocket Lab’s previously announced 20-launch Synspective contract reinforces demand for Electron and supports future launch cadence. Rocket Lab Booked 20 Launches Through 2031
• Neutral Sentiment: Execution remains the key variable: The Iridium transaction is progressing through regulatory and closing steps, while Neutron’s development and schedule will determine whether Rocket Lab can capture demand potentially left by SpaceX’s planned reduction in Falcon 9 rideshare availability.
• Negative Sentiment: Dilution and insider-sale overhang: The Iridium financing could result in as many as 72 million new shares, and Rocket Lab has already raised substantial equity. Recent Form 4 filings also disclosed executive selling, adding supply pressure and investor concern despite the transactions being conducted under a preset trading plan. Rocket Lab Slides as Investors Weigh Iridium Financing and Insider Sales
• Negative Sentiment: Sector-wide selling and valuation concerns: Space stocks are declining together without a new Rocket Lab operational setback, suggesting profit-taking and risk reduction. Investors also remain focused on Rocket Lab’s lack of profitability, high valuation and the execution risk surrounding Iridium and Neutron. Space Stocks Sell Off Together

Wall Street Analysts Forecast Growth

RKLB has been the subject of a number of recent research reports. Roth Capital set a $110.00 price objective on Rocket Lab in a report on Tuesday, August 11th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Rocket Lab in a research note on Friday, July 17th. Berenberg Bank initiated coverage on Rocket Lab in a report on Wednesday, September 2nd. They set a "buy" rating and a $83.00 price objective for the company. Citizens Jmp reiterated a "market outperform" rating and issued a $130.00 target price on shares of Rocket Lab in a research note on Tuesday, August 11th. Finally, KGI Securities upgraded Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 target price for the company in a research note on Monday, July 27th. Four analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $107.20.

Rocket Lab Trading Down 4.2%

The company has a market capitalization of $43.03 billion, a PE ratio of -266.36 and a beta of 2.93. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $70.11 and a two-hundred day moving average of $84.43.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million during the quarter, compared to analysts' expectations of $231.62 million. As a group, sell-side analysts anticipate that Rocket Lab Corporation will post -0.2 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Rocket Lab news, insider Frank Klein sold 45,692 shares of the business's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $3,181,533.96. Following the completion of the sale, the insider owned 961,295 shares in the company, valued at approximately $66,934,970.85. The trade was a 4.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Agostino Ricupati sold 669 shares of the business's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $69.63, for a total transaction of $46,582.47. Following the completion of the transaction, the chief accounting officer owned 26,863 shares in the company, valued at $1,870,470.69. The trade was a 2.43% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 400,749 shares of company stock worth $26,964,474. 8.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Rocket Lab

A number of hedge funds and other institutional investors have recently modified their holdings of RKLB. BlackRock Inc. bought a new stake in Rocket Lab during the second quarter worth about $4,124,970,000. Bank of New York Mellon Corp purchased a new position in shares of Rocket Lab during the second quarter valued at approximately $245,764,000. Bank of America Corp DE bought a new stake in shares of Rocket Lab in the 2nd quarter worth approximately $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Rocket Lab by 14.8% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer's stock worth $278,262,000 after purchasing an additional 352,094 shares in the last quarter. Finally, Amundi grew its stake in shares of Rocket Lab by 22.2% in the 2nd quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer's stock worth $221,673,000 after buying an additional 396,639 shares during the last quarter. 71.78% of the stock is owned by hedge funds and other institutional investors.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab's primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.